Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash from Operations (2018 - 2025)

Dna X (SONM) has disclosed Cash from Operations for 8 consecutive years, with 7034000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 1586.81% year-over-year to 7034000.0, compared with a TTM value of 26031000.0 through Sep 2025, down 501.46%, and an annual FY2024 reading of 8486000.0, down 109.43% over the prior year.
  • Cash from Operations was 7034000.0 for Q3 2025 at Dna X, down from 4882000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 820000.0 in Q2 2023 and bottomed at 17564000.0 in Q4 2021.
  • Average Cash from Operations over 5 years is 4468210.53, with a median of 4217000.0 recorded in 2023.
  • The sharpest move saw Cash from Operations soared 110.9% in 2022, then crashed 5617.86% in 2025.
  • Year by year, Cash from Operations stood at 17564000.0 in 2021, then skyrocketed by 87.34% to 2223000.0 in 2022, then surged by 84.21% to 351000.0 in 2023, then tumbled by 1184.62% to 4509000.0 in 2024, then tumbled by 56.0% to 7034000.0 in 2025.
  • Business Quant data shows Cash from Operations for SONM at 7034000.0 in Q3 2025, 4882000.0 in Q2 2025, and 9606000.0 in Q1 2025.